Hi Jov
Great post. yes - I agree. Only thing I would add - as long as the Ph 1 with Blincyto shows reasonable clinical effectiveness, then I think in the Phase 2 for OnCARlytics they will include a Blincyto arm along with the Azer-Cel arm. The reason: if the Ph 1 trial tells them that OnCARlytics does work with Blincyto, it would make sense to get further proof of that at Phase 2 level.
Dropping Blincyto entirely would be putting all the OnCARlytics eggs into the Azer-Cel basket. OnCARlytics should work with Azer-Cel (and maybe even better than with Blincyto) - but they won't really know that until they do the trial, so I think they will do both.
Cheers
Dave
Hi JovGreat post. yes - I agree. Only thing I would add - as...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $512.3M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.4¢ | 7.0¢ | $1.229M | 17.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 707803 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 172396 | 5 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.001 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.3¢ | 7.0¢ | 6411396 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| IMU (ASX) Chart |